Clinical Applications and Biological Targets Subcommittee: Difference between revisions

Revision as of 20:57, 6 March 2013

Revision as of 20:52, 6 March 2013 view source Jlisiecki (talk \| contribs) Bureaucrats, Administrators 7,000 edits m →Reference Materials ← Older edit		Revision as of 20:57, 6 March 2013 view source Jlisiecki (talk \| contribs) Bureaucrats, Administrators 7,000 edits m →Presentations and Reports Newer edit →
Line 9:		Line 9:


	*[[Media:SWS ~~measurement(s) as~~ biomarker~~(s)~~ of Liver ~~Fibrosis: Towards a Shared Vision~~.pdf\|SWS measurement(s) as biomarker(s) of Liver Fibrosis: Towards a Shared Vision - Claude Cohen-Bacrie, MS]] 25-February-2013		*[[Media:SWS - biomarker of Liver fibrosis-FINAL.pdf\|SWS measurement(s) as biomarker(s) of Liver Fibrosis: Towards a Shared Vision - Claude Cohen-Bacrie, MS]] 25-February-2013

	*[[Media:In Vitro Comparison of Ultrasound Based Elastography Techniques.pdf\|In Vitro Comparison of Ultrasound Based Elastography Techniques (adapted from presentation by Stéphanie Franchi-Abella, MD, Caroline Elie, MD,PhD, Jean-Michel Correas, MD,PhD, ITEC 2012) - Claude Cohen-Bacrie, MS]] 22-October-2012		*[[Media:In Vitro Comparison of Ultrasound Based Elastography Techniques.pdf\|In Vitro Comparison of Ultrasound Based Elastography Techniques (adapted from presentation by Stéphanie Franchi-Abella, MD, Caroline Elie, MD,PhD, Jean-Michel Correas, MD,PhD, ITEC 2012) - Claude Cohen-Bacrie, MS]] 22-October-2012